AI Inflammation Score Improves Heart Risk Prediction

A noncontrast cardiac CT-derived fat attenuation index predicted cardiovascular events beyond coronary artery calcium scoring.

Updated on Nov. 12, 2026 in Heart Disease

AI Inflammation Score Improves Heart Risk Prediction

An AI-derived inflammation score from noncontrast cardiac CT improved cardiovascular risk prediction beyond coronary artery calcium scoring. Its prognostic performance was comparable to the established fat attenuation index measure obtained from coronary CT angiography.

Why it matters

Cardiovascular events often arise from rupture of inflamed, noncalcified plaques that noncontrast CT does not visualize, and absent or low calcium scores do not rule out meaningful residual risk. A score that adds inflammation information could help identify people who appear low-risk on calcium testing alone.

The validation cohort of 19,110 individuals, imaged between 2010 and 2021, was followed for a median of 6.7 years, during which 536 cardiovascular deaths and 1,727 major adverse cardiovascular events were recorded. Whether using the score to guide treatment improves outcomes was not addressed in the findings.

The players

University of Oxford

A public research university in England whose researchers led the multicenter study, with the corresponding author affiliated with the institution.

The details

Researchers evaluated a novel fat attenuation index score derived from noncontrast cardiac CT, which does not require contrast dye. The score's prognostic performance was compared with the established fat attenuation index obtained from coronary CT angiography.

Timeline

  1. Validation cohort imaging took place between 2010 and 2021.

  2. Median follow-up for the cohorts lasted 6.7 years.

Heart Risk Testing

Coronary artery calcium scoring has long been the standard noncontrast scan for estimating heart attack risk, but it misses noncalcified plaques that rupture and cause events. This AI approach adds an inflammation signal to that same routine scan rather than requiring a separate contrast-based test.

Because the score is derived from a noncontrast scan already used for calcium testing, it could in principle add inflammation information without extra contrast exposure. Whether individual patients will have access to this measure depends on future clinical adoption, which the study does not address.

The takeaway

Heart risk assessment may improve by reading inflammation signals from scans already performed for calcium testing. Patients with low calcium scores should not assume their residual cardiovascular risk is negligible.

Further reading

Explore more on Heart Disease to see how imaging and inflammation markers are used to assess cardiovascular risk.

Source note: This article includes information reported by Radiology Business.